ILSI-Biomed Israel

Boston delegation will visit ILSI-BioMed week with over a billion dollars in the pocket to look for investments in Israel

Prepare to meet an official delegation from Boston, Massachusetts, which is expected to visit the up-and-coming ILSI-BioMed week to be held in Tel Aviv between 23-25 May, to hear about the hottest emerging innovations in search for potential investment. The delegation will include senior managers from Massachusetts Life Sciences Center (MLSC), MassMEDIC, a council for initiatives and interests in the field of medical devices, and MassBio, a non-profit organization that represents and provides se...

Meet the speakers: STEPHEN N. OESTERLE, M.D.

STEPHEN N. OESTERLE, M.D. Senior Vice President for Medicine and Technology Stephen N. Oesterle, M.D., joined the company in 2002 as Senior Vice President for Medicine and Technology. In this role, Steve provides executive leadership for Medtronic scientific research, formation of technological strategies and continued development of strong cooperative relationships with the world's medical communities, technical universities, financial institutions and emerging medical device companies...

Meet the speakers: Francois Maisonrouge, Senior Managing Director, Evercore Partners.

Francois Maisonrouge is a Senior Managing Director in advisory business with 25 years of relevant experience. At Evercore, Mr. Maisonrouge was involved in advising Wyeth on its sale to Pfizer, Sanofiaventis on its purchase of Merck's 50% stake in Merial including an option to potentially merge Merial with Intervet / Schering-Plough Animal Health in the future, TPG on its acquisition of IMS Health, De Ruiter on its sale to Monsanto, Bracco on its acquisition of E-Z-Em, and the sale of Op...

Meet The Speakers: Prof. Regina E. Herzlinger

Prof. Regina Herzlinger will give a keynote lecture in the up-and-coming ILSI-BioMed week at the first day, Monday, May 23 2011. Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and the first to serve on a number of corporate boards. She is widely recognized for her innovative research in health care, including her early predictions of the unraveling of ...

BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs

BioMed 2010: Merck-Serono reaches out to collaborate with Israeli companies and entrepreneurs This is done through Inter-lab is the company's R&D center in Israel • Inter-Lab CEO, Regine Shevach: "The Israeli science has a special zest to it, one which we are thrilled to encounter time and time again; Together with Merck Serono, this special zest can create the next blockbuster drug…" Merck Serono, the largest biotechnology company in Europe, is calling on Israeli entrepreneurs and comp...

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...

BioMed 2010 week Innovations: The New Generation of PainShield

NanoVibronix will present the second generation of PainShield – for the treatment of pain and chronic wounds using ultrasound waves Following the commercial success of the first generation PainShield device, for the treatment of (surprise, surprise) pain, especially one that stems from Trigeminal Neualgia, the Israeli company NanoVibronix now reveals the second generation of the device. This time, it has some extra capabilities to treat chronic wounds. NanoVibronix, based in Nesher, is develo...

Stem Cells as Seek-and-Destory Missiles against Cancer

As published in New Scientist, stem cells were succesfully modified to act as seek-and-destroy missiles against cancer in mice brains Stem cells are often viewed as the ultimate solution for regenerative medicine, and for a good cause. Given the correct cues, they can regenerate whole parts of the body, and even re-create an entire embryo (although that would require QUITE some understanding of the cues involved in the process). It seems, however, that now a new use has been found for the...

A Novel Israeli Kit for Regaining Feeling in the Palms

Sheba Hospital will expose a Israeli kit for sensory training, that improves the brain activity for patients who suffer from a decrease in feeling in the palms The Department for Multiple Sclerosis in Sheba Hopsital will present for the first time a novel kit for sensory training, that improves patients' brain activity. The kit will be presented in the BioMed Israel Week 2010, which will be held on July 14th-16th in Tel Aviv. The kit is based on cylinders that come in varied textures, an...

Cardiovascular Therapy in the 2020s

As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv This message is also available online   Cardiovascular Therapy in the 2020s An ILSI-BioMed Workshop Sponsored by As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv.The most acclaimed inte...